Skip to nav Skip to content

Journal Club

March 4, 2020

 All Issues
 Read the last Journal Club Read the next Journal Club 
IDSA Advocating for Federal Coronavirus Response and Improved Access to Testing

IDSA continues to inform the federal government response to COVID-19 and advocate for emergency supplemental federal funding and improved federal policies to ensure that public health and health care systems have what they need to prevent, detect and treat infections.

Read More
CMS Releases Billing Code for SARS-CoV-2

The Centers for Medicare and Medicaid Services recently created a new Healthcare Common Procedure Coding System code to report the laboratory test panel for SARS-CoV-2.

Read More
Do something meaningful: Nominate a colleague

IDSA’s Society Awards celebrate the truly impactful accomplishments of our members. Help celebrate the field of ID by nominating hard working clinicians, promising young researchers, outstanding mentors, and those who have had a lifetime of impact on the field.

Read More
Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.

  • The Impact of an Anti-staphylococcal β-Lactam in Patients with MRSA Bacteremia
  • Chronic Antimicrobial Therapy for Periprosthetic Joint Infection with Implant Retention: Is Longer Better?
  • Antiretroviral Therapy and Neurocognitive Outcomes
  • When to Draw Blood Cultures? A Culture Change May be Needed

Read More
The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities

The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities, an article published Feb. 18 in OFID, is a collaborative effort between IDSA’s ID Training Program Directors’ Committee and many other program directors, based on small-group discussions during the 2018 National ID Program Directors’ Meeting at IDWeek. 

Read More
IDSA Releases New C. diff Infection Clinical Quality Measure

The Guideline Recommended Treatment of Clostridioides difficile Infection (CDI) clinical quality measure is now available for use by health care organizations and clinicians as a tool to ensure they are following guideline recommended treatment for patients with CDI.

Read More
FY 2020 Ending the HIV Epidemic Awards

The Department of Health and Human Services has awarded more than $117 million in funding to health centers and Ryan White programs in targeted U.S. cities, counties and states for expanded HIV testing, treatment, prevention and care services during the first year of the federal Ending the HIV Epidemic initiative, which seeks to bring a 90% reduction in HIV incidence by 2030.

Read More
IDEA Incubator 2020 Applications Now Open

Do you have an original idea to improve ID care? Does this idea include an original invention, product, device or innovative concept for improving ID care? Consider submitting your original idea to the IDSA Foundation’s IDEA Incubator 2020 for a chance to win funding!

Read More
Science Speaks Brings Authority and Experience to COVID-19 Coverage

As a novel coronavirus continues to spread in linked epidemics around the world, IDSA member-authored Science Speaks blog posts continue to shed light on challenges and responses.

Read More
IDSA Experts Answer Important Questions Regarding Growing COVID-19 Outbreak

As the U.S. braces for the possibility of a widespread COVID-19 outbreak, IDSA spokespersons continue to provide credible information in order to educate and abate fear and panic through dozens of media interviews and appearances.

Read More

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.